Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Dodge & Cox
San Francisco,
California
| $3.74B | -$5.43M | 1 | 2.9% | Reduced |
|
| 2 |
Fidelity Investments
Boston,
Massachusetts
| $3.36B | +$255M | 26 | 0.39% | Increased |
|
| 3 |
BlackRock
New York
| $3.24B | +$87.1M | 46 | 0.15% | Increased |
|
| 4 |
Vanguard Group
Malvern,
Pennsylvania
| $2.6B | +$144M | 43 | 0.11% | Increased |
|
| 5 |
Primecap Management
Pasadena,
California
| $1.9B | -$10.9M | 4 | 1.46% | Reduced |
|
| 6 |
Franklin Resources
San Mateo,
California
| $1.61B | -$28M | 8 | 0.77% | Reduced |
|
| 7 |
Capital Research Global Investors
Los Angeles,
California
| $1.49B | +$111M | 4 | 0.44% | Increased |
|
| 8 |
T. Rowe Price Associates
Baltimore,
Maryland
| $1.47B | +$157M | 19 | 0.24% | Increased |
|
| 9 |
State Street
Boston,
Massachusetts
| $1.31B | +$68.7M | 28 | 0.11% | Increased |
|
| 10 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
| $937M | -$16.5M | 2 | 1.16% | Reduced |
|
| 11 |
Wellington Management Group
Boston,
Massachusetts
| $925M | -$148M | 11 | 0.2% | Reduced |
|
| 12 |
Parnassus Investments
San Francisco,
California
| $794M | +$628K | 1 | 3.12% | Increased |
|
| 13 |
Wells Fargo
San Francisco,
California
| $777M | -$7.92M | 40 | 0.22% | Reduced |
|
| 14 |
Brown Brothers Harriman & Co
New York
| $773M | -$74.2M | 5 | 4.25% | Reduced |
|
| 15 |
Bank of America
Charlotte,
North Carolina
| $730M | -$195M | 39 | 0.12% | Reduced |
|
| 16 |
Northern Trust
Chicago,
Illinois
| $709M | +$9.32M | 37 | 0.18% | Increased |
|
| 17 |
TS
Third Security
Radford,
Virginia
| $673M | +$21.2M | 2 | 57.72% | Increased |
|
| 18 |
Fisher Asset Management
Camas,
Washington
| $625M | +$13.6M | 4 | 0.82% | Increased |
|
| 19 |
Loomis, Sayles & Company
Boston,
Massachusetts
| $613M | +$10.4M | 3 | 1.28% | Increased |
|
| 20 |
UBS Group
Zurich,
Switzerland
| $551M | +$987K | 44 | 0.23% | Increased |
|
| 21 |
Morgan Stanley
New York
| $489M | +$21.6M | 45 | 0.13% | Increased |
|
| 22 |
Janus Henderson Group
London,
| $454M | +$32.1M | 3 | 0.28% | Increased |
|
| 23 |
Renaissance Technologies
New York
| $406M | -$10.4M | 28 | 0.45% | Reduced |
|
| 24 |
Goldman Sachs
New York
| $405M | -$14.1M | 33 | 0.1% | Reduced |
|
| 25 |
QF
QVT Financial
New York
| $403M | -$3.85M | 4 | 22.74% | Reduced |
|